Literature DB >> 14999114

HIV drug resistance.

François Clavel1, Allan J Hance.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 14999114     DOI: 10.1056/NEJMra025195

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  243 in total

1.  Computational analysis of HIV-1 protease protein binding pockets.

Authors:  Gene M Ko; A Srinivas Reddy; Sunil Kumar; Barbara A Bailey; Rajni Garg
Journal:  J Chem Inf Model       Date:  2010-10-25       Impact factor: 4.956

2.  Prediction of resistance development against drug combinations by collateral responses to component drugs.

Authors:  Christian Munck; Heidi K Gumpert; Annika I Nilsson Wallin; Harris H Wang; Morten O A Sommer
Journal:  Sci Transl Med       Date:  2014-11-12       Impact factor: 17.956

Review 3.  Resistance-associated variants in chronic hepatitis C patients treated with protease inhibitors.

Authors:  Maya Gambarin-Gelwan; Ira M Jacobson
Journal:  Curr Gastroenterol Rep       Date:  2012-02

4.  Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues.

Authors:  Leandro R Jones; Franco Moretti; Andrea Y Calvo; Darío A Dilernia; Julieta M Manrique; Manuel Gómez-Carrillo; Horacio Salomón
Journal:  AIDS Res Hum Retroviruses       Date:  2011-11-22       Impact factor: 2.205

5.  HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites.

Authors:  Priya S Shah; Nhung P Pham; David V Schaffer
Journal:  Mol Ther       Date:  2012-01-31       Impact factor: 11.454

6.  Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences.

Authors:  Peter Reuther; Benjamin Mänz; Linda Brunotte; Martin Schwemmle; Kerstin Wunderlich
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

7.  Analysis of selection pressure and mutational pattern of HIV type 1 reverse transcriptase region among treated and nontreated patients.

Authors:  Uma Shanmugasundaram; Suniti Solomon; Vidya Madhavan; Murugavel G Kailapuri; Kumarasamy Nagalingeswaran; Sunil Suhas Solomon; Kenneth H Mayer; Balakrishnan Pachamuthu
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09-19       Impact factor: 2.205

8.  Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors.

Authors:  Manabu Aoki; David J Venzon; Yasuhiro Koh; Hiromi Aoki-Ogata; Toshikazu Miyakawa; Kazuhisa Yoshimura; Kenji Maeda; Hiroaki Mitsuya
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  Discordant genotypic resistance and HIV-1 genetic diversity from paired plasma and cerebrospinal fluid samples in Chinese settings.

Authors:  Lifeng Liu; Yulin Zhang; Feili Wei; Qingxia Zhao; Xicheng Wang; Lin Yuan; Ning Li; Dexi Chen
Journal:  J Neurovirol       Date:  2013-01-17       Impact factor: 2.643

10.  Investigation on the mechanism for the binding and drug resistance of wild type and mutations of G86 residue in HIV-1 protease complexed with Darunavir by molecular dynamic simulation and free energy calculation.

Authors:  Dan Li; Ying Zhang; Run-Ning Zhao; Song Fan; Ju-Guang Han
Journal:  J Mol Model       Date:  2014-02-14       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.